Abstract P3-06-15: Baseline CD4/CD8 tumor infiltrating lymphocytes (TIL) ratio predicts pathologic response to neoadjuvant chemotherapy (NC) in breast cancer
García-Martínez, E, Luengo, Gil G, Chaves, Benito A, García, García T, Vicente, Conesa AM, Zafra, Poves M, García, Garre E, Vicente, García V, Ayala, de la Peña F
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article